Package 55319-970-10

{"route": ["ORAL"], "spl_id": "22241b86-a044-4b9c-b7b2-687a4c3faa0c", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0032251920790"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["bfcffa70-94a9-43de-9f22-4ed6a71c0a8d"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Family Dollar (FAMILY WELLNESS)"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 BOX (55319-970-10)  / 100 TABLET in 1 BOTTLE, PLASTIC", "package_ndc": "55319-970-10", "marketing_end_date": "20261231", "marketing_start_date": "20230701"}, {"sample": false, "description": "1 BOTTLE, PLASTIC in 1 BOX (55319-970-24)  / 24 TABLET in 1 BOTTLE, PLASTIC", "package_ndc": "55319-970-24", "marketing_end_date": "20261231", "marketing_start_date": "20230701"}], "brand_name": "Migraine Relief", "product_id": "55319-970_22241b86-a044-4b9c-b7b2-687a4c3faa0c", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "55319-970", "generic_name": "Acetaminophen, Aspirin, Caffeine", "labeler_name": "Family Dollar (FAMILY WELLNESS)", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Migraine Relief", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "ANDA214039", "marketing_category": "ANDA", "marketing_end_date": "20261231", "marketing_start_date": "20230701"}